Section Arrow
DRTS.NASDAQ
- Alpha Tau Medical Ltd
Quotes are at least 15-min delayed:2024/05/16 13:22 EDT
Last
 2.6701
+0.0201 (+0.76%)
Day High 
2.745 
Prev. Close
2.65 
1-M High
2.86 
Volume 
14.92K 
Bid
2.65
Ask
2.68
Day Low
2.67 
Open
2.6797 
1-M Low
2.1501 
Market Cap 
184.63M 
Currency USD 
P/E -- 
%Yield
10-SMA 2.52 
20-SMA 2.5 
50-SMA 2.74 
52-W High 4.8001 
52-W Low 2.1501 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.42/-0.49
Enterprise Value
196.84M
Balance Sheet
Book Value Per Share
1.21
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1046+0.0269+34.62%-- 
DNAGinkgo Bioworks Holdings0.8342-0.0049-0.58%-- 
JAGXJaguar Health0.2851+0.03+11.76%-- 
NBYNovaBay Pharmaceuticals0.1199+0.0154+14.74%-- 
NVAXNovavax13.225+0.325+2.52%-- 
Quotes are at least 15-min delayed:2024/05/16 13:22 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.